ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
2 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
8.8K |
3.3M |
1 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
8.8K
|
3.3M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
8.8K |
3.3M |
1 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
8.8K
|
3.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
2 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
208
|
69K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
5 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
208
|
69K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
7 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
208
|
69K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.8K |
2.9M |
3 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
14 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
6 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
17 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
6 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.3K |
2.6M |
3 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.3K |
2.6M |
4 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
14 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
9 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
17 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
13 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
6 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
dividend
|
|
Wilba32
|
8 |
2.7K |
0 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
8
|
2.7K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.8K |
2.9M |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.8K |
2.9M |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.8K |
2.9M |
6 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wilba32
|
9.8K |
2.9M |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
9 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
208
|
69K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.3K |
2.6M |
18 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
9 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
11 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
5 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
208
|
69K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
2 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
208
|
69K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
15 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
208
|
69K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
5 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
208
|
69K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
32 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
208
|
69K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Wilba32
|
208 |
69K |
9 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
208
|
69K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
6 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
5 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
8.8K |
3.3M |
7 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
8.8K
|
3.3M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wilba32
|
8.8K |
3.3M |
8 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
8.8K
|
3.3M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
12 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
0 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wilba32
|
17K |
6.7M |
12 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
17K
|
6.7M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
31K |
10 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
87
|
31K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
31K |
6 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
87
|
31K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wilba32
|
5.3K |
2.6M |
11 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
31K |
3 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
87
|
31K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
31K |
7 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
87
|
31K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
31K |
7 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
87
|
31K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
6 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Wilba32
|
87 |
31K |
10 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
87
|
31K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Wilba32
|
1.0K |
382K |
10 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.0K
|
382K
|
10
|
|